| 000 | 01565 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515205609.0 | ||
| 264 | 0 | _c20110930 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1097-9867 | ||
| 024 | 7 |
_a10.3109/10837451003592191 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHe, Haibing | |
| 245 | 0 | 0 |
_aPreparation of pH-dependent modified-release pellets of urapidil to improve its bioavailability. _h[electronic resource] |
| 260 |
_bPharmaceutical development and technology _cJun 2011 |
||
| 300 |
_a212-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aExcipients _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 | _aHypromellose Derivatives |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethacrylates _xchemistry |
| 650 | 0 | 4 |
_aMethylcellulose _xanalogs & derivatives |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
| 650 | 0 | 4 |
_aPolymers _xchemistry |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 |
_aTablets, Enteric-Coated _xchemistry |
| 650 | 0 | 4 |
_aTalc _xchemistry |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aLi, Hui | |
| 700 | 1 | _aTang, Xing | |
| 773 | 0 |
_tPharmaceutical development and technology _gvol. 16 _gno. 3 _gp. 212-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10837451003592191 _zAvailable from publisher's website |
| 999 |
_c19522351 _d19522351 |
||